Hims & Hers Health Shares Surge 19% on Q4 Beat & Strong Guidance 
<p><a href='https://financialmodelingprep.com/financial-summary/HIMS'>Hims & Hers Health, Inc. (NYSE:HIMS)</a> shares rose more than 19% since the company’s reported Q4 results on Monday, with EPS of ($0.05) coming in better than the Street estimate of ($0.06). Revenue was $167.2 million, beating the Street estimate of $160.8 million.</p>
<p>The company expects Q1/23 revenue to be in the range of $175-180 million, better than the Street estimate of $163 million. For the full year, the company expects revenue to be in the range of $735-755 million, above the Street estimate of $727 million.</p>
<p>The company provided its 2025 expectations, calling for revenue of at least $1.2 billion and adjusted EBITDA of at least $100 million, both figures trending ahead of the Street estimates. The revenue outlook is consistent with management’s prior commentary of at least a 30% growth rate in the next several years.</p>

NYSE:HIMS